NEU vs PHX

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

NEU

NEUREN FPO NZ [NEU]

44LOW

PHX

PHARMX FPO [PHX]

44LOW

Score Breakdown

NEU PHX
Technical
77
67
Catalyst
50
61
Sentiment
50
50
Fundamental
60
74
Momentum
22
76
Risk Gate
43
50

Key Metrics

NEU Metric PHX
$1.5BMarket Cap$72.5M
705KAvg Volume (20d)682K
+4.4%Short InterestN/A
$22.98552-Week High$0.200
$8.61052-Week Low$0.066
+5.1%Daily Change+4.8%
$11.880Entry Price$0.110
+8.7%ROE-5.9%
+47.1%Profit Margin-12.2%

Active Signals

NEU Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Above-average volume (1.8x) on a green day — buyers stepping up
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Revenue in sharp decline (-81%)

PHX Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (9.5x)
●Small-cap ($20-100M)

Ask Scout AI to compare NEU and PHX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
NEU Full Analysis → PHX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).